EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Mega Lifesciences PCL's Enterprise Value is ฿30,951.39 Mil.
Mega Lifesciences PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ฿1,915.18 Mil. Therefore, Mega Lifesciences PCL's EV-to-FCF for today is 16.16.
The historical rank and industry rank for Mega Lifesciences PCL's EV-to-FCF or its related term are showing as below:
BKK:MEGA-F'
s EV-to-FCF Range Over the Past 10 Years
Min: -203.65 Med: 24.48 Max: 267.47
Current: 16.77
During the past 13 years, the highest EV-to-FCF of Mega Lifesciences PCL was 267.47. The lowest was -203.65. And the median was 24.48.
BKK:MEGA-F's EV-to-FCF is ranked better than 61.36% of 528
companies
in the Drug Manufacturers industry
Industry Median: 23.61
vs BKK:MEGA-F: 16.77
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mega Lifesciences PCL's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mega Lifesciences PCL's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Mega Lifesciences PCL's EV-to-FCF falls into.
Mega Lifesciences PCL's current Enterprise Value is ฿30,951.39 Mil.
Mega Lifesciences PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1,915.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mega Lifesciences PCL (BKK:MEGA-F) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Mega Lifesciences PCL's PE Ratio for today is calculated as:
Mega Lifesciences PCL's share price for today is ฿0.00.
Mega Lifesciences PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Mega Lifesciences PCL EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Mega Lifesciences PCL's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Mega Lifesciences PCL (BKK:MEGA-F) Business Description
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods as well as the provides distribution services relating to such products. The company's products portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purpose and sale of goods manufactured by third parties; and OEM.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BKK:MEGA-F has been successfully added to your 